- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, May 26, 2017
Coverage of our peer-reviewed research in the healthcare and mainstream press.
An article on PatientEngagementHIT.com reported on the findings of a study published in the May 2017 issue of The American Journal of Managed Care® (AJMC®). In “The Association of Mental Health Program Characteristics and Patient Satisfaction,” researchers explored whether veterans’ satisfaction with care was linked with modifiable measures of mental health program reach, service access, program intensity, and treatment continuity. They found positive associations for some of the variables, which could lead to the use of administrative data as a patient satisfaction measure, according to the PatientEngagementHIT.com story.
A VentureBeat article reporting on a startup that will offer virtual reality treatment for stroke victims explained the economic costs of strokes, using data from AJMC® research. The 2010 article, “US Cost Burden of Ischemic Stroke: A Systematic Literature Review,” estimated that nearly 800,000 Americans experience a stroke each year, resulting in direct and indirect costs of over $65 billion.
AJMC® coverage of the recent ISPOR meeting was highlighted in several daily e-newsletters from the National Pharmaceutical Council. The Tuesday e-mail included an article reporting on a session about incorporating stakeholder preferences into value assessments. The Wednesday e-mail featured a video interview with Ilene Hollin, PhD, MPH, who explained how a tailored approach to value assessment is necessary for innovation.
High-Intensity Home-Based Rehabilitation in a Medicare Accountable Care Organization
January 8th 2025High-intensity home-based rehabilitation (HIHR) may substitute for facility-based postacute rehabilitation. Patients in HIHR had better functional outcomes at lower costs than patients in facility-based care.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations
January 7th 2025Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors.
Read More
Stable Patient Satisfaction Found After Switching From the Humira or Biosimilar CT-P17
January 7th 2025A real-world study in France found patient satisfaction was stable after switching from either the reference product or a low-concentration adalimumab biosimilar to the adalimumab biosimilar CT-P17, a high-concentration, citrate-free formulation.
Read More
